Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
09 2020
Historique:
received: 10 06 2020
pubmed: 23 7 2020
medline: 2 3 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

The artificial pancreas system or an automated insulin dosing system has been the 'holy grail' for patients with type 1 diabetes and their caregivers who have over the years wanted to 'close the loop' between monitoring of glucose and delivery of insulin. The launch of the Medtronic MiniMed 670G system in 2017 and the subsequent release of the Tandem t:slim with Control-IQ system, the DANA RS pump compatible-CamAPS FX app and the more recent announcement of the Medtronic MiniMed 780G system have come as answers to their prayers. However, in the time taken to develop and launch these commercial systems, creative and ebullient parents of young patients with type 1 diabetes, along with other patients, technologists and healthcare professionals have developed mathematical models as software solutions to determine insulin delivery that in conjunction with compatible hardware have helped 'close the loop'. Under an umbrella movement #WeAreNotWaiting, they have, as a community, refined and disseminated technologies that are open source and ubiquitously available as do-it-yourself (DIY) closed-loop systems or DIY artificial pancreas systems (APS). There are presently three systems-OpenAPS, AndroidAPS and Loop. We present perspectives of two patients, parent of a patient, and their healthcare providers; the users spanning an age spectrum most likely to use this technology-a child, an adolescent in transitional care and a 31-yr old adult patient, highlighting how looping has helped them self-manage diabetes within the routine of their lives and the challenges they faced.

Identifiants

pubmed: 32696329
doi: 10.1007/s12325-020-01431-w
pii: 10.1007/s12325-020-01431-w
pmc: PMC7444403
doi:

Substances chimiques

Hypoglycemic Agents 0
Insulin 0

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

3929-3941

Références

Lewis D. History and perspective on DIY closed looping. J Diabetes Sci Technol. 2019;13(4):790–3.
doi: 10.1177/1932296818808307
Bekiari E, Kitsios K, Thabit H, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 2018;361:k1310. http://www.bmj.com/content/361/bmj.k1310.abstract .
Bergenstal RM, Garg S, Weinzimer SA, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407–8.
doi: 10.1001/jama.2016.11708
Tauschmann M, Thabit H, Bally L, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet. 2018;392(10155):1321–9.
doi: 10.1016/S0140-6736(18)31947-0
Lewis D, Leibrand S. Real-world use of open source artificial pancreas systems. J Diabetes Sci Technol. 2016;10:1411.
doi: 10.1177/1932296816665635
Lewis DM, Swain RS, Donner TW. Improvements in A1C and time-in-range in DIY Closed-Loop (OpenAPS) Users. Diabetes. 2018;67(Supplement 1):352-OR. http://diabetes.diabetesjournals.org/content/67/Supplement_1/352-OR.abstract .
Litchman ML, Lewis D, Kelly LA, Gee PM. Twitter Analysis of #OpenAPS DIY artificial pancreas technology use suggests improved A1C and quality of life. J Diabetes Sci Technol. 2019;13(2):164–70.
doi: 10.1177/1932296818795705
Choi SB, Hong ES, Noh YH. Open artificial pancreas system reduced hypoglycemia and improved glycemic control in patients with type 1 diabetes. Diabetes. 2018;67(Supplement 1):964-P. http://diabetes.diabetesjournals.org/content/67/Supplement_1/964-P.abstract .
Provenzano V, Guastamacchia E, Brancato D, et al. Closing the loop with OpenAPS in people with type 1 diabetes—experience from Italy. Diabetes. 2018;67(Supplement 1):993-P. http://diabetes.diabetesjournals.org/content/67/Supplement_1/993-P.abstract .
Melmer A, Züger T, Lewis DM, Leibrand SM, Laimer M. 76-OR: In-depth review of glycemic control and glycemic variability in people with type 1 diabetes using open source artificial pancreas systems. Diabetes. 2019;68(Supplement 1):76-OR. http://diabetes.diabetesjournals.org/content/68/Supplement_1/76-OR.abstract .
Street T. #WeAreNotWaiting at the Type1AndTech Conference. http://circles-of-blue.winchcombe.org/index.php/2018/11/11/wearenotwaiting-at-the-type1andtech-conference/ . Accessed June 6, 2020.
OPENAPS.ORG. https://openaps.org/outcomes/ . Accessed June 6, 2020.
Association of British Clinical Diabetologists. Do-it-yourself artificial pancreas system (DIY APS) audit. Diabetol. 2020. https://abcd.care/DIYAPS . Accessed June 6, 2020.
Juvenile Diabetes Research Foundation(JDRF). JDRF UK position statement on type 1 diabetes DIY technologies. https://jdrf.org.uk/about-us/position-statements-reports/position-statements/jdrfs-uk-position-statement-on-type-1-diabetes-diy-technologies/ . Accessed June 6, 2020.
James S, Perry L, Gallagher R, Lowe J. Diabetes educators’ intended and reported use of common diabetes-related technologies: discrepancies and dissonance. J Diabetes Sci Technol. 2016;10(6):1277–86. https://doi.org/10.1177/1932296816646798 .
doi: 10.1177/1932296816646798 pubmed: 27179011 pmcid: 5094322
Wilmot EG, Danne T. DIY artificial pancreas systems: the clinician perspective. Lancet Diabetes Endocrinol. 2020;8(3):183–5.
doi: 10.1016/S2213-8587(19)30416-4
Street T. Diabetech—diabetes and technology. 2019. https://www.diabettech.com/xdrip/libre-accuracy-and-calibration-using-a-third-party-transmitter-a-case-study . Accessed June 6, 2020.

Auteurs

Syed Haris Ahmed (SH)

Department of Endocrinology and Metabolic Medicine, Countess of Chester Hospital NHS Foundation Trust, Chester, UK. asyedharis76@gmail.com.
School of Medicine, University of Liverpool, Liverpool, UK. asyedharis76@gmail.com.

David L Ewins (DL)

Department of Endocrinology and Metabolic Medicine, Countess of Chester Hospital NHS Foundation Trust, Chester, UK.

Jane Bridges (J)

Department of Endocrinology and Metabolic Medicine, Countess of Chester Hospital NHS Foundation Trust, Chester, UK.

Alison Timmis (A)

Department of Children's and Adolescent Services, Countess of Chester Hospital NHS Foundation Trust, Chester, UK.

Nicola Payne (N)

Countess of Chester Hospital NHS Foundation Trust, Chester, UK.

Cormac Mooney (C)

Countess of Chester Hospital NHS Foundation Trust, Chester, UK.

Claire MacGregor (C)

Countess of Chester Hospital NHS Foundation Trust, Chester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH